11:51 AM EST - Tekmira Pharmaceuticals Corporation : announced today its financial and operating results for the third quarter ended September 30, 2012 and provided a corporate update. For Q3 2012, net loss was $3.4 million ($0.25 per common share) as compared to a Q3 2011 net loss of $1.5 million ($0.12 per common share). Revenue was $3.0 million in Q3 2012 as compared to $4.2 million in Q3 2011. Tekmira Pharmaceuticals Corporation
shares T.TKM are trading up $0.89 at $6.00.
